Chong Kun Dang, Stock Price -1.15% at This Time... Individual Investors Net Buy 102,106 Shares in Last 5 Days

As of 2:30 PM on the 1st, Chong Kun Dang is trading at 172,000 KRW, down 1.15% from the previous day. The trading volume is 399,635 shares, which is about 26.57% of the previous day's volume. Chong Kun Dang is known as a top pharmaceutical company in the industry, focusing on therapeutics.

On November 27, Hyungsoo Kim, a researcher at Cape Investment & Securities, stated, "Founded in May 1941 as 'Gungbon Yakbang,' it is a large domestic pharmaceutical company that was split and listed through a holding company conversion in 2013. Since acquiring the sales rights for the major product 'Glatirin,' which was sold by Daewoong Pharmaceutical in 2016, the company has introduced highly marketable original drugs, creating synergy with its own products and driving high sales growth. It is aggressively investing in research and development, currently running a total of 25 projects. The company is securing both cash and future growth." He set the target price for Chong Kun Dang at 200,000 KRW.

Over the past five days, individual investors have net purchased 102,106 shares of Chong Kun Dang, while foreign investors and institutions have net sold 41,175 shares and 65,373 shares, respectively.

※ Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.